RPS6P23

Across TCGA pan-cancer cohorts, RPS6P23 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS6P23’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RPS6P23 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS6P23 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, PRAD, and LUAD are the cancer types where RPS6P23 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS6P23 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.011	.017	6	view →
PRAD	All	All	+0.020	.016	2	view →
LUAD	All	All	+0.015	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS6P23–BRCA

Open the BRCA breakdown →